Literature DB >> 29372911

Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.

Simona Cima, Anna Myriam Perrone, Paolo Castellucci, Gabriella Macchia, Milly Buwenge, Silvia Cammelli, Savino Cilla, Martina Ferioli, Gabriella Ferrandina, Andrea Galuppi, Eugenio Salizzoni, Daniela Rubino, Stefano Fanti, Pierandrea De Iaco, Alessio Giuseppe Morganti.   

Abstract

OBJECTIVE: The aim of this study was to investigate the impact of SUVmax fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) measured in the primary tumor, pelvic and para-aortic node with disease-free survival (DFS) and overall survival (OS) in patients with locally advanced cervical cancer. METHODS AND MATERIALS: A total of 92 patients with histological diagnosis of locally advanced cervical cancer are treated with radiochemotherapy plus brachytherapy boost from January 2008 to April 2014 in our Institution. A pretreatment FDG-PET/CT for staging and radiotherapy planning was performed, and the value of SUVmax measured in primary tumor and positive nodes was related to DFS and OS.
RESULTS: Univariate analysis showed that DFS is related to FDG-PET/CT positive para-aortic nodes (P = 0.01), International Federation of Gynecology and Obstetrics (FIGO) stage of disease (P = 0.01), and primary tumor SUVmax (P = 0.02), and OS is related to positive para-aortic nodes (P = 0.01) and primary tumor SUVmax (P = 0.02).In multivariate analysis, DFS is modified by FDG-PET/CT positive para-aortic lymph nodes, stage and high T SUVmax (P = 0.02; P = 0.003; P = 0.04), but the only worse prognostic factor of OS is the high SUVmax in the primary tumor (P = 0.01).
CONCLUSIONS: We found that T SUVmax, stage, and para-aortic lymph node status assessed by FDG-PET were independent prognostic factors of DFS, whereas only T SUVmax correlated with OS.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29372911     DOI: 10.1097/IGC.0000000000001207

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  8 in total

1.  Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?

Authors:  Marie Voglimacci; Erwan Gabiache; Amélie Lusque; Gwenaël Ferron; Anne Ducassou; Denis Querleu; Stéphanie Motton; Elodie Chantalat; Frédéric Courbon; Alejandra Martinez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-02-07       Impact factor: 9.236

2.  PET/MRI and PET/CT Radiomics in Primary Cervical Cancer: A Pilot Study on the Correlation of Pelvic PET, MRI, and CT Derived Image Features.

Authors:  Shadi A Esfahani; Angel Torrado-Carvajal; Barbara Juarez Amorim; David Groshar; Liran Domachevsky; Hanna Bernstine; Dan Stein; Debra Gervais; Onofrio A Catalano
Journal:  Mol Imaging Biol       Date:  2021-10-07       Impact factor: 3.488

3.  Emerging Role of MicroRNAs in the Therapeutic Response in Cervical Cancer: A Systematic Review.

Authors:  Gloria Ravegnini; Francesca Gorini; Giulia Dondi; Marco Tesei; Eugenia De Crescenzo; Alessio G Morganti; Patrizia Hrelia; Pierandrea De Iaco; Sabrina Angelini; Anna Myriam Perrone
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

4.  Metabolic parameters with different thresholds for evaluating tumor recurrence and their correlations with hematological parameters in locally advanced squamous cell cervical carcinoma: an observational 18F-FDG PET/CT study.

Authors:  Siyao Du; Hongzan Sun; Si Gao; Jun Xin; Zaiming Lu
Journal:  Quant Imaging Med Surg       Date:  2019-03

Review 5.  Diagnostic Accuracy of 18F-FDG-PET/CT and MRI in Predicting the Tumor Response in Locally Advanced Cervical Carcinoma Treated by Chemoradiotherapy: A Meta-Analysis.

Authors:  Sharareh Sanei Sistani; Fateme Parooie; Morteza Salarzaei
Journal:  Contrast Media Mol Imaging       Date:  2021-03-02       Impact factor: 3.161

6.  Prognostic value of posttreatment 18F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameters.

Authors:  Giacomo Maria Lima; Antonella Matti; Giulio Vara; Giulia Dondi; Nicoletta Naselli; Eugenia Maria De Crescenzo; Alessio Giuseppe Morganti; Anna Myriam Perrone; Pierandrea De Iaco; Cristina Nanni; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-02       Impact factor: 9.236

7.  Cervical Cancer: Associations between Metabolic Parameters and Whole Lesion Histogram Analysis Derived from Simultaneous 18F-FDG-PET/MRI.

Authors:  Hans-Jonas Meyer; Sandra Purz; Osama Sabri; Alexey Surov
Journal:  Contrast Media Mol Imaging       Date:  2018-07-30       Impact factor: 3.161

8.  [18F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation.

Authors:  Marta Ferreira; Pierre Lovinfosse; Johanne Hermesse; Marjolein Decuypere; Caroline Rousseau; François Lucia; Ulrike Schick; Caroline Reinhold; Philippe Robin; Mathieu Hatt; Dimitris Visvikis; Claire Bernard; Ralph T H Leijenaar; Frédéric Kridelka; Philippe Lambin; Patrick E Meyer; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-26       Impact factor: 9.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.